Improved Outcomes for Patients Developing Any Immune-Related Adverse Events in Advanced NSCLC Treated With Pembrolizumab Monotherapy

被引：0
|
作者：
Lee, A. [1 ]
Girling, B. [1 ]
Patel, G. [1 ]
Sawhney, P. [1 ]
Luong, M. [1 ]
Ohana, D. [1 ]
Forster, M. [1 ]
Lee, S. [1 ]
机构：
[1] Univ Coll London Hosp, Canc Div, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immunotherapy; NSCLC; Toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA13.06
引用
下载
收藏
页码：S925 / S926
页数：2
相关论文
共 50 条
  • [21] Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    Keraliya, Abhishek
    Bailey, Nancy D.
    Ott, Patrick A.
    Hodi, F. Stephen
    Nishino, Mizuki
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1185 - 1192
  • [22] Characteristics of immune-related adverse events in patients with advanced esophageal cancer treated with nivolumab
    Nakada, Naokatsu
    Ando, Takayuki
    Motoo, Iori
    Kajiura, Shinya
    Fuchino, Mayo
    Sakumura, Miho
    Nanjo, Sohachi
    Mihara, Hiroshi
    Fujinami, Haruka
    Ogawa, Kohei
    Tsukada, Kenichiro
    Nakashima, Koji
    Hosokawa, Ayumu
    Yasuda, Ichiro
    ANNALS OF ONCOLOGY, 2021, 32 : S298 - S298
  • [23] A Multicentric, Retrospective, Real-world Study on Immune-related Adverse Events in Patients with Advanced Non-small Cell Lung Cancers Treated with Pembrolizumab Monotherapy
    Lerner, A.
    Lee, A. J. X.
    Yan, H.
    Van Griethuysen, J.
    Bartlett, A. D.
    Veli, M.
    Jiang, Y.
    Luong, M.
    Naban, N.
    Kane, C.
    Conibear, J.
    Papadatos-Pastos, D.
    Ahmad, T.
    Chao, D.
    Anand, G.
    Asghar, U. S.
    CLINICAL ONCOLOGY, 2024, 36 (03) : 193 - 199
  • [24] ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA TREATED WITH PEMBROLIZUMAB
    Nakamura, Kazutaka
    Toshio, Takagi
    Nemoto, Yuki
    Ishiyama, Yudai
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Fukuda, Hironori
    Shinmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Ishida, Hideki
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2022, 207 (05): : E28 - E28
  • [25] Incidence of thyroid immune-related adverse events in melanoma patients treated with pembrolizumab in an expanded access program
    Jeroen, de Filette
    Yanina, Jansen
    Max, Schreuer
    Hendrik, Everaert
    Brigitte, Velkeniers
    Bart, Neyns
    Bert, Bravenboer
    ACTA CLINICA BELGICA, 2016, 71 : 19 - 19
  • [26] Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma
    Kobayashi, Kazuo
    Suzuki, Kenichi
    Hiraide, Makoto
    Aoyama, Takeshi
    Yokokawa, Takashi
    Shikibu, Sari
    Hashimoto, Koki
    Iikura, Yusuke
    Sato, Hitoshi
    Sugiyama, Erika
    Tajima, Masataka
    Hama, Toshihiro
    ONCOLOGY, 2020, 98 (04) : 237 - 242
  • [27] Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer
    Noguchi, Susumu
    Suminaga, Keiichiro
    Kaki, Takahiro
    Kawachi, Hiroaki
    Fukao, Akari
    Terashita, Satoshi
    Horikawa, Sadao
    Ikeue, Tatsuyoshi
    Sugita, Takakazu
    LUNG CANCER-TARGETS AND THERAPY, 2020, 11 : 53 - 57
  • [28] Immune-related adverse events after a single dose of pembrolizumab
    Vos, Hanne
    Lambein, Kathleen
    Wildiers, Hans
    Punie, Kevin
    Smeets, Ann
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 92 - 94
  • [29] Adverse events in NSCLC patients treated with docetaxel monotherapy
    Liu, Yangyang
    Tyczynski, Jerzy E.
    Zhang, Dongmu
    Choi, Christy
    Wolff, Johannes
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 136 - 136
  • [30] Retrospective study of immune-related adverse events in NSCLC patients treated with PD-1 inhibitors
    Otsubo, Aya
    Ota, Takeshi
    Okajima, Masaaki
    Tanaka, Hiroshi
    Ishida, Takashi
    Iwashima, Akira
    Watanabe, Satoshi
    Sato, Kazuhiro
    Matsumoto, Naoya
    Miyabayashi, Takao
    Terada, Masaki
    Sato, Ko
    Ishikawa, Daisuke
    Tanabe, Yoshinari
    Yoshizawa, Hirohisa
    Kikuchi, Toshiaki
    ANNALS OF ONCOLOGY, 2019, 30
12345